JPH0656649A - Bathing agent composition - Google Patents
Bathing agent compositionInfo
- Publication number
- JPH0656649A JPH0656649A JP4226542A JP22654292A JPH0656649A JP H0656649 A JPH0656649 A JP H0656649A JP 4226542 A JP4226542 A JP 4226542A JP 22654292 A JP22654292 A JP 22654292A JP H0656649 A JPH0656649 A JP H0656649A
- Authority
- JP
- Japan
- Prior art keywords
- agent composition
- bathing
- composition
- weight
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、アトピー性皮膚炎の症
状改善に有効な浴用剤組成物に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a bath agent composition effective for ameliorating the symptoms of atopic dermatitis.
【0002】[0002]
【従来の技術】アトピー(atopy)とは、喘息、
アレルギー性鼻炎、湿疹にかかりやすい家族的傾向、
異種タンパクに対する過敏症、血清中の高レアギン
(IgE)値、血液の好酸球増多などの特徴を有する
アレルギーの一つの型である。アトピー性皮膚炎の臨床
像には幾つかの型があり、皮疹の形態と年齢の関係は厳
密なものではないが、年齢との間には、ある程度の相関
関係があるといわれている。また、皮疹に共通している
ことは、慢性の湿疹であるということ、左右対称性、汎
発性に生じているということである。2. Description of the Related Art Atopy is asthma,
Allergic rhinitis, familial tendency to develop eczema,
It is a type of allergy with characteristics such as hypersensitivity to foreign proteins, high reagin (IgE) level in serum, and eosinophilia in blood. There are several types of clinical features of atopic dermatitis, and the relationship between the form of skin rash and age is not strict, but it is said that there is a certain degree of correlation with age. What is common to skin eruptions is that they are chronic eczema and that they occur bilaterally and universally.
【0003】現在のところ、このアトピー性皮膚炎に対
する根本的な治療法はなく、ステロイド外用剤および鎮
痒剤の内服薬に頼らざるを得ないのが現状である。アト
ピー性皮膚炎の疾患が、慢性の湿疹であるという特徴を
有することから、これら内服薬を用いるには継続的に、
規則正しく、内服薬を服用する必要がある。しかし、実
際には規則正しく内服薬を服用することは難しく、不規
則に内服薬を服用してしまうという問題点がある。ま
た、薬物自体も継続的な作用による、疾患部以外の身体
部分への副作用も心配されるのである。At present, there is no fundamental treatment method for this atopic dermatitis, and it is the present situation that it is unavoidable to rely on the internal use of external steroids and antipruritics. Since the disease of atopic dermatitis has a characteristic of being chronic eczema, it is necessary to continuously use these oral medications.
It is necessary to take internal medicine regularly. However, in practice, it is difficult to take the internal medicine regularly, and there is a problem that the internal medicine is irregularly taken. In addition, there is concern about side effects on body parts other than the diseased part due to the continuous action of the drug itself.
【0004】そこで、アトピー性皮膚炎の臨床皮膚所見
では、乾燥型のものが多く、表皮の乾燥状態を改善する
ことが重要であることから皮膚の保湿能を向上させる浴
用剤を用いれば、入浴を行うことでアトピー性皮膚炎の
症状を改善させることができ、患者の負担を取り除くこ
とができる。そのような目的を持った浴用剤組成物の開
発が望まれていた。[0004] Therefore, in clinical skin findings of atopic dermatitis, many are dry type, and it is important to improve the dry state of the epidermis. Therefore, if a bath agent that improves the moisturizing ability of the skin is used, bathing is possible. By doing, the symptoms of atopic dermatitis can be improved and the burden on the patient can be removed. It has been desired to develop a bath agent composition having such a purpose.
【0005】[0005]
【発明が解決しようとする課題】本発明は、そのような
要望に応えたアトピー性皮膚炎に有効な浴用剤組成物を
提供することを課題としている。SUMMARY OF THE INVENTION An object of the present invention is to provide a bath agent composition which is effective against atopic dermatitis and which meets such a demand.
【0006】[0006]
【課題を解決するための手段】本発明者らは、上記浴用
剤を得るべく鋭意研究を重ねた結果、無機塩類とカンゾ
ウ抽出末と油性成分とを配合した浴用剤組成物により、
上記課題が解決できることを見出し、本発明を完成する
に至った。すなわち、本発明は、無機塩類とカンゾウ抽
出末と常温で液状又はペースト状の油性成分とを主成分
とする浴用剤組成物を提供するものである。以下、本発
明を詳細に説明する。Means for Solving the Problems As a result of intensive studies to obtain the above-mentioned bath agent, the present inventors have found that a bath agent composition containing inorganic salts, licorice extract powder and an oily component,
The inventors have found that the above problems can be solved and completed the present invention. That is, the present invention provides a bath agent composition containing inorganic salts, licorice extract powder, and an oily component which is liquid or paste-like at room temperature. Hereinafter, the present invention will be described in detail.
【0007】本発明において用いられる無機塩類として
は、硫酸ナトリウム、炭素水素ナトリウム、炭酸ナトリ
ウム、セスキ炭酸ナトリウム、塩化ナトリウム、塩化ア
ンモニウム、硝酸ナトリウム、ポリリン酸ナトリウム、
リン酸ナトリウム、酸化カルシウム、炭酸カルシウム、
酸化マグネシウム、硫酸マグネシウム、硫酸アルミニウ
ム、炭酸マグネシウム、塩化カリウム、硫化カリウム、
炭酸カリウム、ミョウバン等が挙げられ、その塩の保湿
能により単独で、又は2種以上を適宜選択、配合でき
る。又、これらの中では炭酸水素ナトリウム、塩化ナト
リウム、硫酸マグネシウム、硫酸ナトリウム、炭酸ナト
リウム、セキス炭酸ナトリウムが好ましく、さらに炭酸
水素ナトリウム(重曹)が特に好ましい。全組成に対す
る配合比は10〜95%(重量)であるが、好ましくは
50〜95%(重量)である。The inorganic salts used in the present invention include sodium sulfate, sodium hydrogencarbonate, sodium carbonate, sodium sesquicarbonate, sodium chloride, ammonium chloride, sodium nitrate, sodium polyphosphate,
Sodium phosphate, calcium oxide, calcium carbonate,
Magnesium oxide, magnesium sulfate, aluminum sulfate, magnesium carbonate, potassium chloride, potassium sulfide,
Potassium carbonate, alum and the like can be mentioned, and depending on the moisturizing ability of the salt, one kind alone or two or more kinds can be appropriately selected and blended. Of these, sodium hydrogen carbonate, sodium chloride, magnesium sulfate, sodium sulfate, sodium carbonate and sodium sesquicarbonate are preferable, and sodium hydrogen carbonate (sodium bicarbonate) is particularly preferable. The compounding ratio based on the total composition is 10 to 95% (weight), preferably 50 to 95% (weight).
【0008】本発明に用いられる油性成分としては、ラ
ノリン、液状ラノリン、ホホバ油、スクワラン、オレン
ジラフィーオイル、ワセリン、流動パラフィン、流動イ
ソパラフィン、オリーブ油、マカデミアンナッツ油等の
天然油、合成油、シリコン類等が挙げられ、単独で、又
は2種以上を適宜選択、配合できる。又、これらの中で
は、ホホバ油、スクワラン、オレンジラフィーオイル、
ローズヒップオイルが好ましく、さらにホホバ油が特に
好ましい。全組成に対する配合比は、0.1〜20%
(重量)であるが、好ましくは1〜10%(重量)であ
る。この配合比が過少であると入浴時のなめらかさ及び
入浴後の肌への充分な保湿効果が得られず、また過剰で
あると肌がべたつくなど好ましくない。Examples of the oily component used in the present invention include lanolin, liquid lanolin, jojoba oil, squalane, orange laffy oil, petrolatum, liquid paraffin, liquid isoparaffin, olive oil, macadamian nut oil and other natural oils, synthetic oils, silicones. And the like, which may be used alone or in combination of two or more. Also, among these, jojoba oil, squalane, orange ruffy oil,
Rosehip oil is preferred, and jojoba oil is particularly preferred. The compounding ratio to the total composition is 0.1-20%
(Weight), but preferably 1 to 10% (weight). If the blending ratio is too small, the smoothness at the time of bathing and the sufficient moisturizing effect on the skin after bathing cannot be obtained, and if it is too large, the skin becomes sticky, which is not preferable.
【0009】本発明に用いられる生薬末はカンゾウの抽
出末であり、その抽出末は常法により水、熱水、溶剤等
で抽出したカンゾウエキス又は更に分画して得たものを
乾燥、粉末化することにより得られたものである。全組
成に対するカンゾウ抽出末の配合比は0.1〜10%
(重量)であるが、好ましくは0.5〜10%(重量)
である。この配合比が過少であると所期の効果が奏され
ず、過剰であってもその増量分に見合った効果の向上は
望めない。The crude drug powder used in the present invention is licorice extract powder, and the extract powder is dried, powdered licorice extract extracted with water, hot water, solvent or the like by a conventional method or the one obtained by further fractionation. It was obtained by converting. Mixing ratio of licorice extract powder to the total composition is 0.1-10%
(Weight), but preferably 0.5 to 10% (weight)
Is. If the compounding ratio is too small, the desired effect is not exhibited, and even if it is excessive, the effect corresponding to the increased amount cannot be expected to be improved.
【0010】又、前記の油性成分などの配合比として
は、油性成分の量が生薬抽出末の0.005倍〜200
倍、好ましくは0.2倍〜10倍がよい。更に本発明の
浴用剤組成物には、前記成分の他に、必要に応じて界面
活性剤類、高分子類、有機酸類、ビタミン類、酵素等を
添加することが出来る。それらの具体例を以下に示す。As for the compounding ratio of the above oily ingredients, the amount of the oily ingredients is 0.005 times to 200 times that of the crude drug extract powder.
Double, preferably 0.2 to 10 times. Further, in addition to the above-mentioned components, surfactants, polymers, organic acids, vitamins, enzymes and the like can be added to the bath agent composition of the present invention, if necessary. Specific examples thereof are shown below.
【0011】界面活性剤としては、ラウリル硫酸ナトリ
ウム、ポリオキシエチレンラウリルエーテル硫酸ナトリ
ウム、ポリオキシエチレンアルキルエーテル硫酸塩、ラ
ウリン酸ジエタノールアミド、ポリオキシエチレングリ
コールモノステアレート等がある。高分子としては、カ
ゼイン、ポリエチレングリコール、デンプン、ポリビニ
ルアルコール、トラガント、ポリビニルピロリドン等が
ある。Examples of the surfactant include sodium lauryl sulfate, sodium polyoxyethylene lauryl ether sulfate, polyoxyethylene alkyl ether sulfate, lauric acid diethanolamide and polyoxyethylene glycol monostearate. Examples of the polymer include casein, polyethylene glycol, starch, polyvinyl alcohol, tragacanth, polyvinylpyrrolidone and the like.
【0012】有機酸としては、コハク酸、リンゴ酸、フ
マル酸、酒石酸、クエン酸などがある。ビタミン類とし
ては、ビタミンA、B、C、D、E等がある。酵素とし
ては、パパイン、ペプシン、トリプシン、フィシン、パ
ンクレアチン等がある。その他、色素、香料、化粧用微
粉体等を使用できる。Organic acids include succinic acid, malic acid, fumaric acid, tartaric acid and citric acid. Examples of vitamins include vitamins A, B, C, D and E. Enzymes include papain, pepsin, trypsin, ficin, pancreatin and the like. In addition, pigments, fragrances, fine powders for cosmetics and the like can be used.
【0013】混合機は、粉体を攪拌、混合するために使
用されるものであればどのようなものでも使用できる。
具体的にはバートオーミキサー、ナウターミキサー、万
能混合攪拌機、リボンミキサー、V字型混合機などを挙
げることができる。混合時間は、成分が均一に混合する
のに必要な時間であれば良く、上記の例に挙げた混合機
を使用する場合には、通常5〜50分間でよい。本発明
の剤型としては、粉末状、顆粒状、錠剤状のいずれにも
限定されない。Any mixer can be used as long as it is used for stirring and mixing powders.
Specific examples thereof include a Bad O mixer, a Nauta mixer, a universal mixer and a mixer, a ribbon mixer, and a V-shaped mixer. The mixing time may be any time required for uniformly mixing the components, and when the mixer described in the above example is used, it is usually 5 to 50 minutes. The dosage form of the present invention is not limited to powder, granules and tablets.
【0014】[0014]
【作用】アトピー性皮膚炎患者に対し本願発明の浴用剤
組成物を用い、4週間の連浴での入浴治療法を施行し、
開始後4週間後の臨床上の皮膚所見(皮膚掻痒感、皮疹
の状態、皮膚乾燥状態)と角質水分量の測定を行ったと
ころ、入浴療法施行前に比較して、角質水分量の上昇、
臨床上の皮膚所見も皮膚掻痒感、皮疹、皮膚乾燥状態に
ついて、良好な改善効果が得られた。又、本発明の浴用
剤組成物には、液状又はペースト状の油性成分が他成分
に含浸しているので、製造工程中で油性成分に由来する
流動性の低下を防止でき、さらに同じ作用効果により保
存時及び使用時にもサラサラとした流動性を保つことが
できる。[Function] Using a bath agent composition of the present invention for patients with atopic dermatitis, a bathing treatment method with continuous bathing for 4 weeks is carried out,
After 4 weeks from the start, clinical skin findings (skin itchiness, skin rash condition, skin dryness) and keratin water content were measured, and keratin water content increased compared to before bathing therapy was administered.
Clinical skin findings also showed good improvement effects on itching, skin rash, and dry skin. Further, since the bath agent composition of the present invention is impregnated with a liquid or paste-like oily component into other components, it is possible to prevent a decrease in fluidity due to the oily component during the production process, and the same effect This makes it possible to maintain a smooth fluidity during storage and use.
【0015】[0015]
【実施例】次に、実施例により本発明をさらに詳細に説
明するが、本発明はこれらの例によって限定されるもの
ではない。EXAMPLES Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
【0016】実施例1 炭酸水素ナトリウム83.4重量部にホホバ油10.0
重量部と香料0.5重量部と色素0.1重量部の混合物
を添加した後、カンゾウエキス末6.0重量部加え、均
一にかき混ぜて目的とする浴用剤組成物を得た。Example 1 Jojoba oil 10.0 was added to 83.4 parts by weight of sodium hydrogen carbonate.
After adding a mixture of 1 part by weight, 0.5 part by weight of perfume, and 0.1 part by weight of pigment, 6.0 parts by weight of licorice extract powder was added, and the mixture was stirred uniformly to obtain a desired bath preparation composition.
【0017】実施例2 実施例1と同様にして下記の配合によるアトピー性皮膚
炎用浴用剤組成物を製造した。この浴用剤組成物も実施
例1の浴用剤組成物と同様の優れた効果を有している。 塩化ナトリウム 89.4重量部 スクワラン 6.0重量部 甘草エキス末 4.0重量部 香料 0.5重量部 色素 0.1重量部Example 2 A bath composition for atopic dermatitis having the following composition was produced in the same manner as in Example 1. This bath agent composition also has the same excellent effects as the bath agent composition of Example 1. Sodium chloride 89.4 parts by weight Squalane 6.0 parts by weight Licorice extract powder 4.0 parts by weight Fragrance 0.5 parts by weight Pigment 0.1 parts by weight
【0018】実施例3 実施例1と同様にして下記の配合によるアトピー性皮膚
炎用浴用剤組成物を製造した。この浴用剤組成物も実施
例1の浴用剤組成物と同様の優れた効果を有している。 硫酸マグネシウム 93.4重量部 オレンジラフィーオイル 4.0重量部 甘草エキス末 2.0重量部 香料 0.5重量部 色素 0.1重量部Example 3 In the same manner as in Example 1, a bath agent composition for atopic dermatitis having the following composition was produced. This bath agent composition also has the same excellent effects as the bath agent composition of Example 1. Magnesium sulfate 93.4 parts by weight Orange Raffy oil 4.0 parts by weight Licorice extract powder 2.0 parts by weight Fragrance 0.5 parts by weight Pigment 0.1 parts by weight
【0019】実施例4 実施例1と同様にして下記の配合によるアトピー性皮膚
炎用浴用剤組成物を製造した。この浴用剤組成物も実施
例1の浴用剤組成物と同様の優れた効果を有している。 硫酸ナトリウム 91.4重量部 ローズヒップオイル 5.0重量部 甘草エキス末 3.0重量部 香料 0.5重量部 色素 0.1重量部Example 4 A bath composition for atopic dermatitis having the following composition was produced in the same manner as in Example 1. This bath agent composition also has the same excellent effects as the bath agent composition of Example 1. Sodium sulfate 91.4 parts by weight Rosehip oil 5.0 parts by weight Licorice extract powder 3.0 parts by weight Fragrance 0.5 parts by weight Pigment 0.1 parts by weight
【0020】実施例5(アトピー性皮膚炎に対する本発
明浴用剤組成物の有効性試験) アトピー性皮膚炎患者21名を、夫々実施例1で得た浴
用剤組成物30gを200リットルの浴湯中に溶かした
40℃の浴湯に10分間入浴せしめる方法で4週間連浴
させた。各患者に対し、問診表、ケースカードを用いて
2週間毎に臨床検査、自覚症状の改善度を調べ、且つ医
師による判定を行い、最後に4週間目に総合判定を行い
アトピー性皮膚炎に対する有効性を評価した。Example 5 (Efficacy test of the bath preparation composition of the present invention against atopic dermatitis) Twenty-one patients with atopic dermatitis were treated with 30 g of the bath preparation composition obtained in Example 1 in 200 liters of bath water. The solution was continuously bathed for 4 weeks by a method in which it was soaked in a bath water of 40 ° C. for 10 minutes. For each patient, a clinical examination and a degree of improvement of subjective symptoms are checked every 2 weeks using a medical inquiry sheet and a case card, and a doctor makes a judgment, and finally a comprehensive judgment is made in the 4th week for atopic dermatitis. The effectiveness was evaluated.
【0021】その結果を表1、表2、表3に示す。表
1、表2、表3にみるように本発明の浴用剤組成物を用
いると、入浴療法施行前に比較して角質水分量が上昇
し、臨床上の皮膚所見も皮膚掻痒感、皮疹、皮膚乾燥状
態について良好な改善効果があることがわかる。The results are shown in Tables 1, 2 and 3. As shown in Table 1, Table 2 and Table 3, when the bath agent composition of the present invention is used, the amount of keratin water is increased as compared with that before the bathing therapy is performed, and clinical skin findings include pruritus rash, skin rash, It can be seen that there is a good improving effect on dry skin.
【0022】比較例1 比較例1として、下記の配合による従来の浴用剤組成物
を用いて実施例5と同様の試験を行った。その結果を表
4、表5、表6に示す。なお、比較例1のパネラーは2
0名とした。 硫酸ナトリウム 94.4重量部 スクワラン 5.0重量部 香料 0.5重量部 色素 0.1重量部Comparative Example 1 As Comparative Example 1, the same test as in Example 5 was conducted using a conventional bath agent composition having the following composition. The results are shown in Tables 4, 5, and 6. The number of panelists in Comparative Example 1 was 2
There were 0 people. Sodium sulfate 94.4 parts by weight Squalane 5.0 parts by weight Perfume 0.5 parts by weight Pigment 0.1 parts by weight
【0023】[0023]
【表1】 [Table 1]
【0024】[0024]
【表2】 [Table 2]
【0025】[0025]
【表3】 [Table 3]
【0026】[0026]
【表4】 [Table 4]
【0027】[0027]
【表5】 [Table 5]
【0028】[0028]
【表6】 [Table 6]
【0029】実施例6(本発明の浴用剤組成物の粉末流
動性及び官能評価) 実施例1で得た浴用剤組成物の流動性をパウダーテスタ
ー(ホリカワミクロン社製)を用いて安息角を測定し、
次の評価基準で評価を行ったところ○(流動性良好)で
あった。 ○……流動性良好 △……すこしボタつく ×……流動性が乏しく、ボタつく又は固化するExample 6 (Powder fluidity and sensory evaluation of bath agent composition of the present invention) The fluidity of the bath agent composition obtained in Example 1 was measured by using a powder tester (manufactured by Horikawa Micron Co., Ltd.). Measure
When evaluated according to the following evaluation criteria, the result was ◯ (good fluidity). ○: Good fluidity △: Slight fluffing ×: Poor fluidity and fluffing or solidification
【0030】次にパネラー30名により、実施例1で得
た浴用剤組成物を30g/200リットルの割合で浴湯
に使用した時の入浴時のなめらかさ及び入浴後の保湿感
について官能評価を行った。評価基準は次の通りであ
る。 ○……なめらかさ、保湿感ともあり △……どちらともいえない ×……なし 結果は○であった。Next, 30 panelists conducted a sensory evaluation on the smoothness during bathing and the moisturizing sensation after bathing when the bath agent composition obtained in Example 1 was used in a bath water at a rate of 30 g / 200 liters. went. The evaluation criteria are as follows. ◯ ... Smoothness and moisturizing feeling are present. △ ... Neither can be said. × …… None The result was ◯.
【0031】[0031]
【発明の効果】本発明の浴用剤組成物にはアトピー性皮
膚炎の症状を改善するという効果がある。又、アトピー
性皮膚炎の患者でない一般の人が使用した場合において
も、入浴時の感触がなめらかであるとともに、入浴後充
分な保湿感を与えるという効果がある。更に本発明の浴
用剤組成物では、油性成分を多量配合しても、粉体の流
動性を経時的にも損なうことがないので、製造の際のト
ラブルがなく、又、容器からの取り出しも容易となると
いう効果もある。The bath composition of the present invention has the effect of improving the symptoms of atopic dermatitis. Further, even when used by a general person who is not a patient with atopic dermatitis, there is an effect that the feel during bathing is smooth and a sufficient moisturizing sensation is given after bathing. Furthermore, in the bath agent composition of the present invention, even if a large amount of an oily component is blended, the fluidity of the powder is not impaired over time, so there is no trouble during production, and it is also possible to take it out of the container. There is also an effect that it becomes easy.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 関 太輔 富山県富山市安養坊665−1 (72)発明者 諸橋 正昭 富山県富山市呉羽水上町64−59 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Daisuke Seki 665-1 Anyobo, Toyama City, Toyama Prefecture (72) Inventor Masaaki Morohashi 64-59 Kureha Mizukami Town, Toyama City, Toyama Prefecture
Claims (3)
又はペースト状の油性成分とを主成分とする浴用剤組成
物。1. A bath agent composition comprising an inorganic salt, licorice extract powder, and an oily component which is liquid or paste-like at room temperature.
求項1記載の浴用剤組成物。2. The bath agent composition according to claim 1, wherein the inorganic salt is sodium hydrogen carbonate.
は2記載の浴用剤組成物。3. The bath agent composition according to claim 1, wherein the oily component is jojoba oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4226542A JP2828185B2 (en) | 1992-08-04 | 1992-08-04 | Bath composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4226542A JP2828185B2 (en) | 1992-08-04 | 1992-08-04 | Bath composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0656649A true JPH0656649A (en) | 1994-03-01 |
JP2828185B2 JP2828185B2 (en) | 1998-11-25 |
Family
ID=16846785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4226542A Expired - Fee Related JP2828185B2 (en) | 1992-08-04 | 1992-08-04 | Bath composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2828185B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0899889A (en) * | 1994-08-02 | 1996-04-16 | Taisho Pharmaceut Co Ltd | Therapeutic agent for atopic dermatitis |
JP2003063946A (en) * | 2001-08-22 | 2003-03-05 | Maruzen Pharmaceut Co Ltd | Bathing agent composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61286317A (en) * | 1985-06-13 | 1986-12-16 | Osaka Chem Lab | Bathing agent |
JPH04108727A (en) * | 1990-08-27 | 1992-04-09 | Lion Corp | Bath agent composition |
-
1992
- 1992-08-04 JP JP4226542A patent/JP2828185B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61286317A (en) * | 1985-06-13 | 1986-12-16 | Osaka Chem Lab | Bathing agent |
JPH04108727A (en) * | 1990-08-27 | 1992-04-09 | Lion Corp | Bath agent composition |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0899889A (en) * | 1994-08-02 | 1996-04-16 | Taisho Pharmaceut Co Ltd | Therapeutic agent for atopic dermatitis |
JP2003063946A (en) * | 2001-08-22 | 2003-03-05 | Maruzen Pharmaceut Co Ltd | Bathing agent composition |
Also Published As
Publication number | Publication date |
---|---|
JP2828185B2 (en) | 1998-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100411837B1 (en) | Preparations and methods for reducing skin irritation | |
JP4058199B2 (en) | Warm feeling pack | |
US5017367A (en) | Skin treatment preparation | |
JPH0892051A (en) | Deodorizing cosmetic excellent in resistance to discoloration and dispersibility | |
BR0215551B1 (en) | Composition for the treatment of moist skin and moisturizing process and skin protection. | |
KR101508168B1 (en) | Keratotic plug regrowth inhibition agent, keratotic plug regrowth inhibition method, and keratotic plug regrowth inhibition kit | |
RU2290920C2 (en) | Composition for moist skin | |
CN111631965A (en) | Plant-derived facial mask with cleaning and makeup removing functions | |
JP2004123543A (en) | Skin care preparation for external use | |
JPH0647535B2 (en) | Anti-inflammatory composition | |
WO2004060340A1 (en) | Oily skin preparation for external use | |
HU230039B1 (en) | Hypoallergenic and non-irritant skin care formulations | |
US7485316B2 (en) | Wet-skin treatment compositions using specific gum and acrylate systems for enhanced rheology | |
JPH0393707A (en) | Oil-in-water type emulsion cosmetic | |
JPS63280006A (en) | Agent for suppressing irritant feeling of skin and cosmetic containing said agent | |
JPH0656649A (en) | Bathing agent composition | |
JPH11263721A (en) | Oil-in-water type gommage (peeling) cosmetic | |
KR20220027633A (en) | Cosmetic Composition Containing LHA Crystal Pearl Effective For Improving Skin Trouble | |
JP2000290163A (en) | Moisturizing cream | |
JP2004203764A (en) | Multi-layer type cosmetic | |
JPH09263528A (en) | Cosmetic | |
JP3527334B2 (en) | Lotion | |
JP5814495B2 (en) | Obesity improving agent | |
JP2003342160A (en) | External preparation for skin | |
JPH07187991A (en) | Bathing agent containing essence of perilla frutescens and essence of chamomile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080918 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080918 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090918 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090918 Year of fee payment: 11 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090918 Year of fee payment: 11 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090918 Year of fee payment: 11 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090918 Year of fee payment: 11 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100918 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100918 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110918 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110918 Year of fee payment: 13 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110918 Year of fee payment: 13 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |